Comparative in vitro safety analysis of dyes for chromovitrectomy: Indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green

Retina

Volumn 31, Issue 6, 2011, Pages 1128-1136

  Balaiya, Sankarathi ^a   Brar, Vikram S ^a   Murthy, Ravi K ^a   Chalam, Kakarla V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

brilliant blue G; bromophenol blue; chromovitrectomy; ICG; infracyanine green; RGC; RPE; surgical dyes

Indexed keywords

BRILLIANT BLUE GREEN; BROMOPHENOL BLUE; DYE; INDOCYANINE GREEN; INFRACYANINE GREEN; LIPOCORTIN 5; NEUTRAL RED; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DEATH; CELL VIABILITY; CHROMOVITRECTOMY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG SAFETY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PIGMENT EPITHELIUM; RAT; RETINA GANGLION CELL; TIME; VITRECTOMY;

ANIMALS; APOPTOSIS; BROMPHENOL BLUE; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; FLOW CYTOMETRY; HUMANS; INDOCYANINE GREEN; RATS; RETINAL GANGLION CELLS; RETINAL PIGMENT EPITHELIUM; ROSANILINE DYES; VITRECTOMY;

EID: 79958291687     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181fe543a     Document Type: Article

References (25)

1. Abdelkader E, Lois N. Internal limiting membrane peeling in vitreo-retinal surgery. Surv Ophthalmol 2008;53:368-396. (Pubitemid 351843441)
2. Da Mata AP, Riemann CD, Nehemy MB, et al. Indocyanine green-assisted internal limiting membrane peeling for macular holes to stain or not to stain? Retina 2005;25:395-404. (Pubitemid 40791875)
3. Smiddy WE, Michels RG, De Bustros S, De laCruzZ, GreenWR. Histopathology of tissue removed during vitrectomy for impending idiopathic macular holes. Am J Ophthalmol 1989;108:360-364. (Pubitemid 19259197)
4. Yoshida M, Kishi S. Pathogenesis of macular hole recurrence and its prevention by internal limiting membrane peeling. Retina 2007;27:169-173.
5. Kwok AK, Lai TY, Man-Chan W, Woo DC Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 2003;87:71-74. (Pubitemid 36071782)
6. Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004;137:609-614. (Pubitemid 38446672)
7. Uemura A, Kanda S, Sakamoto Y Kita H. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peel-ing. Am J Ophthalmol 2003;136:252-257. (Pubitemid 36904071)
8. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A.Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841. (Pubitemid 35425451)
9. Engelbrecht NE, Freeman J, Sternberg P Jr, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peel-ing. Am J Ophthalmol 2002;133:89-94. (Pubitemid 34076506)
10. Rivett K,Kruger L, Radloff S. Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference? Graefes Arch Clin Exp Ophthalmol 2004242:393-396.
11. Enaida H, Hisatomi T, Hata Y et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006;26:631-636. (Pubitemid 44620362)
12. Haritoglou C, Schumann RG, Strauss R, Priglinger SG, Neubauer AS, Kampik A. Vitreoretinal surgery using bromo-phenol blue as a vital stain: evaluation of staining characteristics in humans. Br J Ophthalmol 2007;91:1125-1128. (Pubitemid 47344880)
13. Enaida H, Hisatomi T, Goto Y et al. Preclinical investigation of internal limiting membrane staining and peeling using intra-vitreal brilliant blue G Retina 2006;26:623-630. (Pubitemid 44620361)
14. Rodrigues EB, Penha FM, Farah ME, et al. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 2009;29:497-510.
15. Repetto G, Del Peso A, Zurita JL. Neutral red uptake assay for the estimation ofcell viability/cytotoxicity. Nat Protoc. 2008;3: 1125-1131.
16. Haritoglou C, Yu A, Freyer W, et al. An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci. 2005;46:3315-3322. (Pubitemid 44264321)
17. Yuen D, Gonder J, Proulx A, Liu H, Hutnik C. Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green. Am J Ophthalmol 2009;147:251-259.
18. Farah ME, Maia M, Rodrigues EB. Dyes in ocular surgery: principles for use in chromovitrectomy Am J Ophthalmol 2009;148:332-340.
19. Rodrigues EB, Penha FM, De Paula Fiod Costa E, et al. Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 2010;149:265-277.
20. Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004;45:3697-3703. (Pubitemid 39298588)
21. Hisatomi T, Enaida H, Matsumoto H, et al. Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining. Arch Ophthalmol 2006;124:514-519.
22. Remy M, Thaler S, Schumann RG, et al. An in vivo evaluation of brilliant blue G in animals and humans. BJO 2008;92: 1142-1147.
23. SchuettaufF, Haritoglou C, May CA, et al. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 2006;47:3573-3578. (Pubitemid 351639726)
24. Weinberger AW, Kirchhof B, Mazinani BE, Schrage NF. Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery. Graefes Arch Clin Exp Ophthalmol. 2001;239:388-390. (Pubitemid 32600198)
25. Kawahara S, Hata Y Miura M, et al. Intracellular events in retinal glial cells exposed to ICG and BBG. Invest Ophthalmol Vis Sci. 2007;48:4426-4432. (Pubitemid 351260955)